Cargando…
The Efficacy of Single-Dose Intravitreal Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-VEGF Therapy: Real-Life Results
OBJECTIVES: To investigate the efficacy, safety, and side effect profiles of a single-dose intravitreal dexamethasone implant (IDI, Ozurdex) in patients with diabetic macular edema (DME) refractory to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: This study included 101 eyes of 78...
Autores principales: | Simsek, Mert, Citirik, Mehmet, Ozates, Serdar, Tekin, Kemal, Ozkoyuncu, Dilara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784452/ https://www.ncbi.nlm.nih.gov/pubmed/35098061 http://dx.doi.org/10.14744/bej.2020.06977 |
Ejemplares similares
-
The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
por: Simsek, Mert, et al.
Publicado: (2018) -
Quantitative analysis of the optic nerve head parameters in patients with age-related macular degeneration
por: ŞİMŞEK, Mert, et al.
Publicado: (2019) -
Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016) -
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021) -
Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema
por: Bilici, Serdar, et al.
Publicado: (2023)